Vertigo, a common and distressing clinical symptom, often presents a diagnostic challenge to healthcare professionals. It is characterized by a sensation of spinning or movement, either of self or surrounding objects. This article aims to provide a comprehensive clinical approach to vertigo, enabling physicians to better diagnose and manage this condition.
Vertigo is a symptom, not a disease, often resulting from a dysfunction in the vestibular system. Differentiating between peripheral and central causes is crucial as it significantly impacts the management and prognosis of the patient. Peripheral vertigo is more common and is usually benign, whereas central vertigo might indicate serious neurological conditions.
A thorough clinical history and physical examination form the cornerstone of vertigo evaluation. Key points to consider include onset, duration, frequency, and associated symptoms. The Dix-Hallpike maneuver and Head Impulse Test are valuable bedside tests for peripheral vertigo. Neurological examination and imaging may be required in cases suspected of central vertigo.
Management of vertigo is multifaceted, involving symptomatic treatment, vestibular rehabilitation, and addressing the underlying cause. Medications such as vestibular suppressants and antiemetics provide symptomatic relief. Vestibular rehabilitation exercises improve balance and reduce dizziness. In refractory cases or when a serious underlying condition is identified, specialist referral is warranted.
Vertigo is a complex symptom with a wide range of potential causes. A systematic clinical approach is essential to differentiate between peripheral and central vertigo, which is critical for appropriate management. By understanding the nuances of vertigo, healthcare professionals can improve patient outcomes through precise diagnosis and targeted treatment strategies.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation